Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Cell Communication and Signaling : CCS|March 2, 2023
Cancer immune evasion through KRAS and PD-L1 and potential therapeutic interventionsAlex Watterson, Matthew A CoelhoBJC Reports|February 27, 2025
Breaking barriers: we need a multidisciplinary approach to tackle cancer drug resistanceJames Ingham, Jia-Ling Ruan, Matthew A CoelhoGenome Biology|April 27, 2026
BEstimate: a computational tool for the design and interpretation of CRISPR base editing experimentsCansu Dinçer, Bo Fussing, Mathew J Garnett, et al.Cell Reports Methods|May 14, 2024
Analyzing the functional effects of DNA variants with gene editingSarah Cooper, Sofia Obolenski, Andrew J Waters, et al.Nature Communications|August 19, 2020
CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAsMatthew A Coelho, Etienne De Braekeleer, Mike Firth, et al.Genome Biology|January 15, 2024
scSNV-seq: high-throughput phenotyping of single nucleotide variants by coupled single-cell genotyping and transcriptomicsSarah E Cooper, Matthew A Coelho, Magdalena E Strauss, et al.BMC Biology|December 30, 2018
BE-FLARE: a fluorescent reporter of base editing activity reveals editing characteristics of APOBEC3A and APOBEC3BMatthew A Coelho, Songyuan Li, Luna Simona Pane, et al.Nature Communications|September 9, 2015
Involvement of a eukaryotic-like ubiquitin-related modifier in the proteasome pathway of the archaeon Sulfolobus acidocaldariusRana S Anjum, Sian M Bray, John K Blackwood, et al.Cell Reports. Medicine|January 21, 2026
CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistanceAlex Watterson, Gabriele Picco, Vivien Veninga, et al.Immunity|December 17, 2017
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNAMatthew A Coelho, Sophie de Carné Trécesson, Sareena Rana, et al.Pageof 2